Impact of oncogenic pathways on evasion of antitumour immune responses
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Cancer"
DOI: 10.1038/nrc.2017.117
Abstract: Immunotherapeutic interventions are showing effectiveness across a wide range of cancer types, but only a subset of patients shows clinical response to therapy. Responsiveness to checkpoint blockade immunotherapy is favoured by the presence of a… read more here.
Keywords: pathways evasion; immune responses; evasion antitumour; impact oncogenic ... See more keywords
Clinical impact of oncogenic KRASdosage variation in pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.4027
Abstract: 4027 Background: Some studies have reported that KRAS oncogenic dosage variation plays a critical role in the biology and phenotype diversification of pancreatic ductal adenocarcinoma (PDA). However, this has not been confirmed in large-scale data.… read more here.
Keywords: clinical impact; variation; group; impact oncogenic ... See more keywords